About Biomage
Biomage is a company based in Glasgow (United Kingdom) founded in 2019 was acquired by Parse Biosciences in January 2024. Biomage has raised $1.51 million across 3 funding rounds from investors including Parse Biosciences and IndieBio. The company has 6 employees as of June 30, 2021. Biomage offers products and services including Cellenics and scRNA-seq Course. Biomage operates in a competitive market with competitors including DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
- Headquarter Glasgow, United Kingdom
- Employees 6 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomage Ltd
- Date of Incorporation 07 May, 2019
- Jurisdiction EDINBURGH, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.51 M (USD)
in 3 rounds
-
Latest Funding Round
$1.26 M (USD), Seed
Jan 01, 2021
-
Investors
Parse Biosciences
& 1 more
-
Employee Count
6
as on Jun 30, 2021
-
Acquired by
Parse Biosciences
(Jan 16, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomage
Biomage offers a comprehensive portfolio of products and services, including Cellenics and scRNA-seq Course.
Open-source tool for exploring single-cell RNA-seq datasets without coding.
Online training for single-cell RNA sequencing data analysis techniques.
People of Biomage
Unlock access to complete
Unlock access to complete
Funding Insights of Biomage
Biomage has successfully raised a total of $1.51M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.26 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomage
Biomage has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Parse Biosciences and IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked | |
|
RNA-sequencing transcriptome kits for health data analysis are developed.
|
Locked | Locked | Locked |
Investor details for Biomage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomage
Investment portfolio details for Biomage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomage
Detailed financials for Biomage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomage Comparisons
Peer comparison for Biomage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomage
Biomage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Depixus, Genomics, Seven Bridges Genomics and Hexagon Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| Locked | Locked | Locked |
Genomic risk assessment and prevention platform is provided.
|
|
| Locked | Locked | Locked |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| Locked | Locked | Locked |
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
|
|
| Locked | Locked | Locked |
DNA sequencing technology is developed to detect genomic mutations.
|
Detailed competitors of Biomage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomage
Complete news archive for Biomage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomage
Biomage was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Biomage is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Adam Kurkiewicz is the current CEO of Biomage.
Biomage is a funded company, having raised a total of $1.51M across 3 funding rounds to date.
As of Jun 30, 2021, the latest employee count at Biomage is 6.
Biomage was founded in 2019 and is based in Glasgow, United Kingdom. Operations focus on the biotechnology sector, where a cloud-based platform is offered for analyzing single-cell data. Tools are included for data integration, sequencing, bioimaging, and visualization. Graphical representations of cell distribution, cellular contents, and sequencing data are generated. Insights into analytical processes are supported for researchers in genomics and related fields.
Biomage's top competitors include DNAnexus, Depixus and Ingenuity Systems.
Biomage offers Cellenics and scRNA-seq Course.
Biomage has 2 investors. Key investors include Parse Biosciences, and IndieBio.
The valuation of Biomage is $3.91K as of Apr 2020.